Who
Wettan Keeley M. Cain
EVP Gen Counsel, Legal & Comp
Company insider
Files Form 4 as: EVP Gen Counsel, Legal & Comp, Gilead Sciences.
In numbers
- Trades disclosed
- 30
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 27 Feb 2026
- Last trade
- 10 Sep 2026
- Last filed
- 11 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Sep 2026filed 11 Sep 2026 | GILD Gilead SciencesBiotechnology | SEC FORM 4 Code M | —590 | filing |
| 10 Sep 2026filed 11 Sep 2026 | GILD Gilead SciencesBiotechnology | SEC FORM 4 Code F | $41K285 at $144.81 | filing |
| 10 Sep 2026filed 11 Sep 2026 | GILD Gilead Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —590 | filing |
| 10 Sep 2026filed 11 Sep 2026 | GILD Gilead Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —590 | filing |
| 10 Sep 2026filed 11 Sep 2026 | GILD Gilead SciencesBiotechnology | SEC FORM 4 Code M | —590 | filing |
| 10 Sep 2026filed 11 Sep 2026 | GILD Gilead SciencesBiotechnology | SEC FORM 4 Code F | $41K285 at $144.81 | filing |
| 10 Aug 2026filed 11 Aug 2026 | GILD Gilead SciencesBiotechnology | SEC FORM 4 Code M | —6,002 | filing |
| 10 Aug 2026filed 11 Aug 2026 | GILD Gilead SciencesBiotechnology | SEC FORM 4 Code F | $387K2,908 at $133.06 | filing |
| 10 Aug 2026filed 11 Aug 2026 | GILD Gilead Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,002 | filing |
| 10 Aug 2026filed 11 Aug 2026 | GILD Gilead Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,002 | filing |
| 10 Aug 2026filed 11 Aug 2026 | GILD Gilead SciencesBiotechnology | SEC FORM 4 Code M | —6,002 | filing |
| 10 Aug 2026filed 11 Aug 2026 | GILD Gilead SciencesBiotechnology | SEC FORM 4 Code F | $387K2,908 at $133.06 | filing |
| 10 Jun 2026filed 11 Jun 2026 | GILD Gilead SciencesBiotechnology | SEC FORM 4 Code M | —589 | filing |
| 10 Jun 2026filed 11 Jun 2026 | GILD Gilead SciencesBiotechnology | SEC FORM 4 Code F | $34K283 at $121.48 | filing |
| 10 Jun 2026filed 11 Jun 2026 | GILD Gilead Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —589 | filing |
| 10 Jun 2026filed 11 Jun 2026 | GILD Gilead Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —589 | filing |
| 10 Jun 2026filed 11 Jun 2026 | GILD Gilead SciencesBiotechnology | SEC FORM 4 Code M | —589 | filing |
| 10 Jun 2026filed 11 Jun 2026 | GILD Gilead SciencesBiotechnology | SEC FORM 4 Code F | $34K283 at $121.48 | filing |
| 10 Mar 2026filed 12 Mar 2026 | GILD Gilead SciencesBiotechnology | SEC FORM 4 Code M | —1,246 | filing |
| 10 Mar 2026filed 12 Mar 2026 | GILD Gilead SciencesBiotechnology | SEC FORM 4 Code F | $90K606 at $148.56 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.